New pill targets root of asthma inflammation in global trial
Disease control
Not yet recruiting
This study is testing an experimental pill called linvemastat as an add-on treatment for adults whose moderate-to-severe asthma isn't fully controlled by their standard inhalers. About 135 participants will take either the new drug or a placebo pill daily for 16 weeks while conti…
Phase: PHASE2 • Sponsor: Foresee Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC